Lidinete Mangabeira da Silva
Research Subjects
Lidinete Mangabeira da Silva has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Izabel Almeida Alves
Universidade Federal da Bahia
1 shared publication Joslene Lacerda Barreto
1 shared publication- Keli Jaqueline Staudt
Universidade Federal do Rio Grande do Sul
1 shared publication
Latest Publications
- Open Access
- 21 May 2026
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- p. 1-10
Evaluation of sleep quality during pharmacotherapeutic: follow-up
Introduction: Pharmacotherapeutic monitoring (PM) in mental health can lead to significant benefits for patients; however, the involvement of clinical pharmacists in this context is underdiscussed in literature. Often, the addition of new medications is carried out to address complaints brought by patients, as is the case with insomnia complaints, where benzodiazepines are commonly added to pharmacotherapy. Objective: The aim of this study was to assess the sleep quality of psychiatric patients enrolled in a pharmacotherapeutic monitoring service within a public mental health outpatient clinic. Method: A total of 16 patients were included in the analysis. Patient data obtained from the Medical Records of the Pharmaceutical Clinical Service under the Ministry of Health were utilized. The assessment tools employed included PSQI-Br, PHQ-9, and GAD-7, with further analysis conducted using the multiple linear regression test to explore the relationship between various variables and the PSQI-Br score. Results: The findings revealed that 68.75% of the patients exhibited sleep disturbances, 61.53% displayed moderate to severe depressive symptoms, and 35.7% showed severe anxiety levels. Significant correlation was observed between PSQI scores and the total hours of sleep (p = 0.003). A total of 83 pharmaceutical interventions were implemented as part of the treatment regimen. Conclusios: The study concludes that a considerable proportion of mental health patients experience poor sleep quality or an underlying sleep disorder, posing challenges in the management of their condition. Therefore, it is imperative to prioritize the evaluation of sleep quality to mitigate psychological deterioration and enhance the effectiveness of drug therapy by incorporating strategies focusing on sleep hygiene within the framework of the Unified Health System.
- 21 May 2026
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- p. 1-10
Open AccessEvaluation of sleep quality during pharmacotherapeutic: follow-up
Introduction: Pharmacotherapeutic monitoring (PM) in mental health can lead to significant benefits for patients; however, the involvement of clinical pharmacists in this context is underdiscussed in literature. Often, the addition of new medications is carried out to address complaints brought by patients, as is the case with insomnia complaints, where benzodiazepines are commonly added to pharmacotherapy. Objective: The aim of this study was to assess the sleep quality of psychiatric patients enrolled in a pharmacotherapeutic monitoring service within a public mental health outpatient clinic. Method: A total of 16 patients were included in the analysis. Patient data obtained from the Medical Records of the Pharmaceutical Clinical Service under the Ministry of Health were utilized. The assessment tools employed included PSQI-Br, PHQ-9, and GAD-7, with further analysis conducted using the multiple linear regression test to explore the relationship between various variables and the PSQI-Br score. Results: The findings revealed that 68.75% of the patients exhibited sleep disturbances, 61.53% displayed moderate to severe depressive symptoms, and 35.7% showed severe anxiety levels. Significant correlation was observed between PSQI scores and the total hours of sleep (p = 0.003). A total of 83 pharmaceutical interventions were implemented as part of the treatment regimen. Conclusios: The study concludes that a considerable proportion of mental health patients experience poor sleep quality or an underlying sleep disorder, posing challenges in the management of their condition. Therefore, it is imperative to prioritize the evaluation of sleep quality to mitigate psychological deterioration and enhance the effectiveness of drug therapy by incorporating strategies focusing on sleep hygiene within the framework of the Unified Health System.